In October 2024, Pharmac introduced funded diabetes technology for people living with type 1 diabetes. Most people who choose to use this technology are now established on CGM, and more than 60 per cent are using insulin pumps or automated insulin delivery systems.
As more of these patients begin requesting prescriptions for pump and CGM consumables through primary care, we’ve created this guide to support you with the prescribing process. If you need further assistance, please reach out to your regional diabetes lead:
Kathy joined Pinnacle earlier this month as clinical diabetes specialist for Waikato, replacing the role previously held by Anne Waterman.
Read moreFrom 1 December 2025, Pharmac will remove Special Authority renewal requirements for several treatments, including insulin pump consumables, continuous glucose monitors, LAMA/LABA inhalers, epoetin alfa, budesonide capsules, and febuxostat.
Read moreFunding for patients who require a follow-up appointment following HbA1c retest by Awanui Labs.
View detailsA guide for clinical management of type 2 diabetes, to support nurses at all levels to develop their knowledge and clinical reasoning in diabetes care.